Washington University St. Louis George Warren Brown School: Study Links GLP-1 Drugs to Lower Heart Risks in People With Serious Mental Illness
October 28, 2026
October 28, 2026
ST. LOUIS, Missouri, Oct. 28 (TNSjou) -- The Washington University St. Louis George Warren Brown School issued the following news:
* * *
Study links GLP-1 drugs to lower heart risks in people with serious mental illness
Myra Lopez
10/27/2026
GLP-1 medications, including semaglutide and tirzepatide, are associated with lower risks of heart attack, heart failure and death among adults with serious mental illness, Type 2 diabetes and . . .
* * *
Study links GLP-1 drugs to lower heart risks in people with serious mental illness
Myra Lopez
10/27/2026
GLP-1 medications, including semaglutide and tirzepatide, are associated with lower risks of heart attack, heart failure and death among adults with serious mental illness, Type 2 diabetes and . . .
